drugdeliverybusiness2h
FDA clears Tandem Diabetes Care’s next-gen automated insulin delivery algorithm for type 2 diabetes
Tandem Diabetes Care announced that the FDA cleared its Control-IQ+ automated insulin delivery algorithm for people with type ...
Business Wire3h
Tandem Diabetes Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
Control-IQ+ automated insulin delivery technology from Tandem Diabetes Care cleared by FDA for people with type 2 diabetes.
The Financial Express6h
Popular artificial sweetener linked to higher risk of heart attack and stroke
Long-term use of artificial sweeteners may heighten the risk of stroke, heart disease and even premature death.